Navigation Links
Kronos Announces First Quarter Business Update and Financial Results
Date:11/15/2007

ement with EOL, Kronos' medical partner for manufacturing and distributing Kronos air purifiers in Russia and other Commonwealth of Independent States.

In addition, EOL provided further independent technology testing and validation of the Kronos technology. The Russian National Healthcare Institution Vladimir Regional Tuberculosis Prevention and Treatment Center conducted in-patient room testing to assess the effectiveness of Kronos-based air purifiers for use in disinfecting rooms used to treat TB patients. Dr. Volchenkov, Chief Physician for the Regional Tuberculosis Prevention and Treatment Center concluded the Kronos-based air purifier demonstrated "a high reliable decrease in the microorganisms in the room." Dr. Volchenkov further stated that the Kronos-based "device can be used for air cleaning and disinfection in the rooms of tuberculosis prevention and treatment centers having high infection rates."

Intellectual Property.

During the quarter, Kronos obtained two additional foreign patents. This brings Kronos' total patent portfolio to thirteen U.S. patents and five international patents with additional patents pending.

Financial Results

Kronos recorded a net loss for each of the quarters ended September 30, 2007 and September 30, 2006 of $1,463,000 and $843,000, respectively. The increase in the net loss in the quarter ended September 30, 2007 was principally the result of a $301,000 increase in operating costs to $1,054,000, and a $335,000 increase in interest expense to $435,000.

Revenues for the quarter ended September 30, 2007 were $25,000 compared to $19,000 for the comparable period of 2006. Revenues for the quarter ended September 30, 2007 consisted of fees from our license agreement with EOL. Selling, General and Administrative expenses for the quarter ended September 30, 2007 increased $301,000 from the corresponding period of 2006 to $1,054,000. The increase was principally the result of a $207,000 increase in com
'/>"/>

SOURCE Kronos Advanced Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... Trinity Biotech plc (Nasdaq: TRIB ... products for the point-of-care and clinical laboratory markets, ... wholly-owned subsidiary (the "Issuer"), intends to offer, subject ... principal amount of Exchangeable Senior Notes due 2045 ... pursuant to Rule 144A under the Securities Act ...
(Date:4/1/2015)... 2015  Hologic, Inc. (NASDAQ: HOLX ) announced ... Convertible Exchange Senior Notes due 2037 (CUSIP No. 436440 ... the trustee, paying agent and conversion agent for the ... This conversion right is subject to the terms of ... December 10, 2007, as supplemented by the second supplemental ...
(Date:4/1/2015)... NORTHBROOK, Ill. and ASPEN, Colo. ... Inc., in partnership with the Chris Klug Foundation (CKF), is ... Nominations are now being accepted for the award, which ... post-transplant quality of life, whether it is a career ... leading a fulfilling life with family and loved ones. ...
Breaking Medicine Technology:Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 2Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 3Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 4Hologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2037 are Eligible to Convert 2Astellas Teams Up with The Chris Klug Foundation on the Bounce Back Award to Recognize Extraordinary Transplant Recipients 2Astellas Teams Up with The Chris Klug Foundation on the Bounce Back Award to Recognize Extraordinary Transplant Recipients 3
... Reportlinker.com announces that a new market research report ... Reportlinker Adds Pharma 101: An Overview of the ... http://www.reportlinker.com/p0155107/Reportlinker-Adds-Pharma-101-An-Overview-of-the-Life-Sciences-Industry-(Analyst-Insight).html , Introduction , The life ... the proper background, it can be difficult for ...
... 16 Reportlinker.com announces that a ... in its catalogue. , ... Market Outlook To 2014: Policy environment, ... , http://www.reportlinker.com/p0155347/Reportlinker-Adds-The-Middle-Eastern-Pharmaceutical-Market-Outlook-To-2014-Policy-environment-market-structure-competitive-landscape-growth-opportunities.html ...
Cached Medicine Technology:Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight) 2Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 2Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 3Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 4Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 5Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 6Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 7Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 8Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 9Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 10Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 11
(Date:4/1/2015)... York (PRWEB) April 01, 2015 The ... of Risperdal lawsuits ( http://www.risperdallawsuit2014.com/ ) has scheduled ... calendar for the Philadelphia Court of Common Pleas, the ... 206, City Hall. Court records indicate that the proceeding ... on behalf of Risperdal users who experienced gynecomastia (male ...
(Date:4/1/2015)... Chicago, IL, Northfield, IL, Bethesda, MD, Alexandria, VA ... American Society for Clinical Pathology (ASCP), the College ... Pathology (AMP), and the American Society of Clinical ... clinical practice guideline on the use of molecular ... colorectal carcinoma. This evidence-based guideline will help establish ...
(Date:4/1/2015)... Dr. Daniel C. Stewart ... to discuss the benefits of the LANAP® treatment over ... periodontal disease. People who live in Howard County, and ... can now visit Dr. Stewart, a Maryland dentist, for ... the LANAP® protocol, which is a laser gum surgery ...
(Date:4/1/2015)... 2015 GrassrootsHealth, an international nonprofit ... medical education (CME) courses about vitamin D ... more confident in measuring, prescribing, and tracking vitamin ... these CME courses, practitioners can apply for D*certification ... available are “Vitamin D, Sunshine, Optimal Health: Putting ...
(Date:4/1/2015)... Miramar, FL (PRWEB) April 01, 2015 ... has received Provisional Certificate of Authority (PCOA) approval from ... important step in the ongoing development of a retirement ... enrich individual health, wellness and spiritual development. , America’s ... prepared to meet the housing needs of seniors, according ...
Breaking Medicine News(10 mins):Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 2Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 3Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 2Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 3Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 4Health News:Dr. Daniel C. Stewart Offers Columbia Area Residents an Informational Seminar in April About Less Invasive Gum Disease Treatment Now Available at Smile Savers Dentistry 2Health News:Dr. Daniel C. Stewart Offers Columbia Area Residents an Informational Seminar in April About Less Invasive Gum Disease Treatment Now Available at Smile Savers Dentistry 3Health News:GrassrootsHealth Launches CME Courses about Vitamin D 2Health News:GrassrootsHealth Launches CME Courses about Vitamin D 3Health News:Casa Sant’Angelo Receives Approval for New Retirement Living 2
... Federal Emergency Management Agency (FEMA) of America is under ... stamped on warnings from its own field workers ... housed in government-provided trailers were exposed to levels of ... U.S. workers. ,A trail of e-mails obtained ...
... Thursday banned artificial trans fat and required nutrition labeling for ... applies to Seattle and most of its suburbs despite objections ... produced when hydrogen is added to vegetable oil, increase the ... been linked to obesity, heart disease and diabetes. ...
... People's Congress deputy has called on the Chinese Government ... commercials, at least during the summer and winter holiday ... been convinced about this after hearing her eight-year-old daughter ... don't like fat girls after watching a TV ad ...
... magazine 'Computing Which?' has compiled a list of 101 ... access to advice on almost every matter ranging from ... ,Although the journal has enlisted websites pertaining ... of the most useful and popular sources, such as ...
... lifetime risk of cancer associated with radiation exposure from ... with the risk greater for women and younger patients, ... models. ,The study, published in the journal ... by Andrew J. Einstein, at the Columbia University College ...
... that mature heart cells can not only replicate, but also ... environment. ,The researchers noted that a sponge-like ... the injury can help heart cells to begin dividing and ... component of the material that surrounds cells and is derived ...
Cached Medicine News:Health News:Katrina Evacuees Made To Remain In Toxic Air 2Health News:Artificial Trans Fat Banned in Chain Restaurant in King County 2Health News:101 Websites That can Change Your Life Enlisted 2Health News:Women, Younger Patients at Greater Lifetime Cancer Risk from CT Scan 2Health News:Scientists Demonstrate Heart Cell Replication in Mice 2
... liquid stable reagent offers the laboratory ... stability to help maximize laboratory productivity, ... result turnaround time. The patented technology ... a long shelf life that will ...
... liquid stable reagent offers the laboratory ... stability to help maximize laboratory productivity, ... result turnaround time. The proprietary technology ... a long shelf life that will ...
... Lithium single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... reagent provides a long shelf life ...
... single liquid stable reagent offers the ... liquid stability to help maximize laboratory ... quick result turnaround time. The proprietary ... reagent provides a long shelf life ...
Medicine Products: